EX3 Investigating Time to Next Treatment As a Surrogate Endpoint for Overall Survival in Previously Untreated Intermediate- to Poor-Risk Advanced Renal Cell Carcinoma Patients: An Insight from the Phase III CheckMate-214
Branchoux, S., Sofeu, C.L., Kurt, M., Gaudin, A.F., Italiano, A., Rondeau, V., Bellera, C.
Published in Value in health (01.12.2020)
Published in Value in health (01.12.2020)
Get full text
Journal Article
PCN29 Time to Next Treatment As a Candidate Surrogate Endpoint for Overall Survival in Previously Untreated Advanced Melanoma Patients Treated with Immune-Checkpoint Inhibitors
Branchoux, S., Sofeu, C.L., Gaudin, A.F., Kurt, M., Moshyk, A., Italiano, A., Bellera, C., Rondeau, V.
Published in Value in health (01.12.2020)
Published in Value in health (01.12.2020)
Get full text
Journal Article
Time to next treatment or death as a candidate surrogate endpoint for overall survival in advanced melanoma patients treated with immune checkpoint inhibitors: an insight from the phase III CheckMate 067 trial
Branchoux, S., Sofeu, C.L., Gaudin, A.-F., Kurt, M., Moshyk, A., Italiano, A., Bellera, C., Rondeau, V.
Published in ESMO open (01.02.2022)
Published in ESMO open (01.02.2022)
Get full text
Journal Article
Accès à la prise en charge de l’infection VIH pédiatrique – État des lieux de l’offre des soins au Cameroun en 2014
Penda, C.I., Zoung Kanyi Bissek, A.-C., Téjiokem, M.C., Sofeu, C.L., Eboumbou Moukoko, E.C., Ateba Ndongo, F., Njock, L.R., Koki Ndombo, P.O.
Published in Revue d'épidémiologie et de santé publique (01.08.2020)
Published in Revue d'épidémiologie et de santé publique (01.08.2020)
Get full text
Journal Article